Marine Bio (MBII) Misses Q3 EPS by 7c

Marine Bio (NASDAQ: MBII) reported Q3 EPS of ($0.29), $0.07 worse than the analyst estimate of ($0.22). Revenue for the quarter came in at $3.6 million versus the consensus estimate of $3.66 million.

For earnings history and earnings-related data on Marine Bio (MBII) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Hydrofarm Holdings Group, Inc. (HYFM) Misses Q2 EPS by 134c
• Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c